References
- World Health Organization. Assessment of medicines regulatory systems in sub-saharan African Countries. An Overview of Findings from 26 Assessment Reports; 2010. cited 2021 Jan 15]. Available from 2021 Jan 15: https://www.who.int/healthsystems/Assessment26African_countries.pdf
- Caturla Goñi M. Accelerating regulatory approvals through the World Health Organization collaborative registration procedures. Pharm Policy Law. 2016;18:109–120.
- World Health Organization. WHO support for medicines regulatory harmonization in Africa: focus on East African Community. cited 2021 Jan 15]. Available from 2021 Jan 15: https://www.who.int/medicines/publications/druginformation/DI_28-1_Africa.pdf?ua=1
- World Health Organization. Good reliance practices in the regulation of medical products: high level principles and considerations. cited 2021 Jun 29]. Available from 2021 Jun 29: https://www.who.int/publications/i/item/55th-report-of-the-who-expert-committee-on-specifications-for-pharmaceutical-preparations* Guideline describing the use of the concept of reliance
- World Health Organization. Good regulatory practices in the regulation of medical products. cited 2021 Apr 16]. Available from 2021 Apr 16: https://www.who.int/publications/i/item/55th-report-of-the-who-expert-committee-on-specifications-for-pharmaceutical-preparations
- World Health Organization [Internet]. List of Stringent Regulatory Authorities (SRAs). cited 2021 Jan 15]. Available from 2021 Jan 15: https://www.who.int/initiatives/who-listed-authority-reg-authorities/SRAs
- World Health Organization [Internet]. WHO-Listed Authority (WLA). cited 2021 Jul 27]. Available from 2021 Jul 27: https://www.who.int/initiatives/who-listed-authority-reg-authorities
- World Health Organization. Collaborative procedure in the assessment and accelerated national registration of pharmaceutical products and vaccines approved by stringent regulatory authorities. cited 2021 Jan 15]. Available from 2021 Jan 15:http://apps.who.int/iris/bitstream/handle/10665/272452/9789241210195-eng.pdf?ua=1** Guideline explaining the SRA CRP in detail.
- World Health Organization [Internet]. Accelerated registration of medicines approved by SRAs. cited 2020 Dec 18]. Available from 2020 Dec 18: https://extranet.who.int/pqweb/medicines/faster-registration-fpps-approved-sras** Overview of the procedure
- World Health Organization. Procedure for prequalification of pharmaceutical products. cited 2021 Jan 17]. Available from 2021 Jan 17: https://www.who.int/medicines/areas/quality_safety/quality_assurance/TRS961_Annex10.pdf
- World Health Organization. Good practices of national regulatory authorities in implementing the collaborative registration procedures for medical products. cited 2021 Jan 17]. Available from 2021 Jan 17: https://apps.who.int/iris/bitstream/handle/10665/312316/9789241210287-eng.pdf?ua=1* Guideline on the implementation of collaborative registration procedures
- Regulation (EC) No 726/2004 of the European parliament and of the council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. cited 2021 Jan 15]. Available from 2021 Jan 15: https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf
- Cavaller Bellaubi M, Harvey Allchurch M, Lagalice C, et al. The European Medicines Agency facilitates access to medicines in low- and middle-income countries. Expert Review of Clinical Pharmacology. 2020;13(3):321–325. 10.1080/17512433.2020.1724782.